Year |
Citation |
Score |
2016 |
Heir P, Srikumar T, Bikopoulos G, Bunda S, Poon BP, Lee JE, Raught B, Ohh M. Oxygen-Dependent Regulation of Erythropoietin Receptor Turnover And Signaling. The Journal of Biological Chemistry. PMID 26846855 DOI: 10.1074/Jbc.M115.694562 |
0.324 |
|
2012 |
Ho JJ, Metcalf JL, Yan MS, Turgeon PJ, Wang JJ, Chalsev M, Petruzziello-Pellegrini TN, Tsui AK, He JZ, Dhamko H, Man HS, Robb GB, Teh BT, Ohh M, Marsden PA. Functional importance of Dicer protein in the adaptive cellular response to hypoxia. The Journal of Biological Chemistry. 287: 29003-20. PMID 22745131 DOI: 10.1074/Jbc.M112.373365 |
0.344 |
|
2011 |
Russell RC, Sufan RI, Zhou B, Heir P, Bunda S, Sybingco SS, Greer SN, Roche O, Heathcote SA, Chow VW, Boba LM, Richmond TD, Hickey MM, Barber DL, Cheresh DA, ... ... Ohh M, et al. Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia. Nature Medicine. 17: 845-53. PMID 21685897 DOI: 10.1038/Nm.2370 |
0.64 |
|
2011 |
Roos FC, Evans AJ, Brenner W, Wondergem B, Klomp J, Heir P, Roche O, Thomas C, Schimmel H, Furge KA, Teh BT, Thüroff JW, Hampel C, Ohh M. Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma. The American Journal of Pathology. 178: 853-60. PMID 21281817 DOI: 10.1016/j.ajpath.2010.10.033 |
0.461 |
|
2010 |
Niemeyer CM, Kang MW, Shin DH, Furlan I, Erlacher M, Bunin NJ, Bunda S, Finklestein JZ, Sakamoto KM, Gorr TA, Mehta P, Schmid I, Kropshofer G, Corbacioglu S, Lang PJ, ... ... Ohh M, et al. Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nature Genetics. 42: 794-800. PMID 20694012 DOI: 10.1038/Ng.641 |
0.593 |
|
2010 |
Roos FC, Roberts AM, Hwang II, Moriyama EH, Evans AJ, Sybingco S, Watson IR, Carneiro LA, Gedye C, Girardin SE, Ailles LE, Jewett MA, Milosevic M, Wilson BC, Bell JC, ... ... Ohh M, et al. Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus. Embo Molecular Medicine. 2: 275-88. PMID 20623734 DOI: 10.1002/Emmm.201000081 |
0.309 |
|
2010 |
Wang Y, Ohh M. Oxygen-mediated endocytosis in cancer. Journal of Cellular and Molecular Medicine. 14: 496-503. PMID 20082654 DOI: 10.1111/j.1582-4934.2010.01016.x |
0.33 |
|
2009 |
Sufan RI, Moriyama EH, Mariampillai A, Roche O, Evans AJ, Alajez NM, Vitkin IA, Yang VX, Liu FF, Wilson BC, Ohh M. Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex. Embo Molecular Medicine. 1: 66-78. PMID 20049704 DOI: 10.1002/Emmm.200900004 |
0.309 |
|
2009 |
Wang Y, Roche O, Yan MS, Finak G, Evans AJ, Metcalf JL, Hast BE, Hanna SC, Wondergem B, Furge KA, Irwin MS, Kim WY, Teh BT, Grinstein S, Park M, ... ... Ohh M, et al. Regulation of endocytosis via the oxygen-sensing pathway. Nature Medicine. 15: 319-24. PMID 19252501 DOI: 10.1038/Nm.1922 |
0.324 |
|
2008 |
Koeman JM, Russell RC, Tan MH, Petillo D, Westphal M, Koelzer K, Metcalf JL, Zhang Z, Matsuda D, Dykema KJ, Houseman HL, Kort EJ, Furge LL, Kahnoski RJ, Richard S, ... ... Ohh M, et al. Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. Plos Genetics. 4: e1000176. PMID 18773095 DOI: 10.1371/journal.pgen.1000176 |
0.59 |
|
2008 |
Russell RC, Ohh M. NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL. Embo Reports. 9: 486-91. PMID 18323857 DOI: 10.1038/embor.2008.19 |
0.608 |
|
2007 |
Maynard MA, Evans AJ, Shi W, Kim WY, Liu FF, Ohh M. Dominant-negative HIF-3 alpha 4 suppresses VHL-null renal cell carcinoma progression. Cell Cycle (Georgetown, Tex.). 6: 2810-6. PMID 17998805 DOI: 10.4161/cc.6.22.4947 |
0.314 |
|
2007 |
Gervais ML, Henry PC, Saravanan A, Burry TN, Gallie BL, Jewett MA, Hill RP, Evans AJ, Ohh M. Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 87: 1252-64. PMID 17906660 DOI: 10.1038/labinvest.3700684 |
0.405 |
|
2007 |
Russell RC, Ohh M. The role of VHL in the regulation of E-cadherin: a new connection in an old pathway. Cell Cycle (Georgetown, Tex.). 6: 56-9. PMID 17245122 DOI: 10.4161/cc.6.1.3668 |
0.654 |
|
2007 |
Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW, Kim WY, Saravanan A, Maynard MA, Gervais ML, Sufan RI, Roberts AM, Wilson LA, Betten M, Vandewalle C, ... ... Ohh M, et al. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Molecular and Cellular Biology. 27: 157-69. PMID 17060462 DOI: 10.1128/MCB.00892-06 |
0.648 |
|
2006 |
Hwang II, Watson IR, Der SD, Ohh M. Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response. Journal of Virology. 80: 10712-23. PMID 16928739 DOI: 10.1128/JVI.01014-06 |
0.325 |
|
2006 |
Calzada MJ, Esteban MA, Feijoo-Cuaresma M, Castellanos MC, Naranjo-Suárez S, Temes E, Méndez F, Yánez-Mo M, Ohh M, Landázuri MO. von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. Cancer Research. 66: 1553-1560. PMID 16452212 DOI: 10.1158/0008-5472.Can-05-3236 |
0.368 |
|
2004 |
Stickle NH, Chung J, Klco JM, Hill RP, Kaelin WG, Ohh M. pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development. Molecular and Cellular Biology. 24: 3251-61. PMID 15060148 DOI: 10.1128/Mcb.24.8.3251-3261.2004 |
0.377 |
|
2004 |
Qi H, Gervais ML, Li W, DeCaprio JA, Challis JR, Ohh M. Molecular cloning and characterization of the von Hippel-Lindau-like protein. Molecular Cancer Research : McR. 2: 43-52. PMID 14757845 |
0.383 |
|
2002 |
Ohh M, Kim WY, Moslehi JJ, Chen Y, Chau V, Read MA, Kaelin WG. An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. Embo Reports. 3: 177-82. PMID 11818338 DOI: 10.1093/Embo-Reports/Kvf028 |
0.316 |
|
Show low-probability matches. |